Literature DB >> 23564314

Chronic inflammatory demyelinating polyneuropathy.

Mazen M Dimachkie1, Richard J Barohn.   

Abstract

OPINION STATEMENT: Chronic Inflammatory polyneuropathies are an important group of neuromuscular disorders that present chronically and progress over more than 8 weeks, being referred to as chronic inflammatory demyelinating polyneuropathy (CIDP). Despite tremendous progress in elucidating disease pathogenesis, the exact triggering event remains unknown. Our knowledge regarding diagnosis and management of CIDP and its variants continues to expand, resulting in improved opportunities for identification and treatment. Most clinical neurologists will be involved in the management of patients with these disorders, and should be familiar with available therapies for CIDP. We review the distinctive clinical, laboratory, and electro-diagnostic features that aid in diagnosis. We emphasize the importance of clinical patterns that define treatment responsiveness and the most appropriate therapies in order to improve prognosis.

Entities:  

Year:  2013        PMID: 23564314      PMCID: PMC3987657          DOI: 10.1007/s11940-013-0229-6

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  116 in total

1.  Electrophysiologic correlations with clinical outcomes in CIDP.

Authors:  Vera Bril; Marta Banach; Marinos C Dalakas; Chunqin Deng; Peter Donofrio; Kim Hanna; Hans-Peter Hartung; Richard A C Hughes; Hans Katzberg; Norman Latov; Ingemar S J Merkies; Pieter A Van Doorn
Journal:  Muscle Nerve       Date:  2010-10       Impact factor: 3.217

2.  Interferon beta-1a as an investigational treatment for CIDP.

Authors:  J-M Vallat; A F Hahn; J-M Léger; D P Cros; L Magy; F Tabaraud; P Bouche; P-M Preux
Journal:  Neurology       Date:  2003-04-01       Impact factor: 9.910

3.  Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP.

Authors:  C Sommer; S Koch; M Lammens; A Gabreels-Festen; G Stoll; K V Toyka
Journal:  Neurology       Date:  2005-12-27       Impact factor: 9.910

4.  Antiganglioside antibodies in multifocal acquired sensory and motor neuropathy.

Authors:  Armin Alaedini; Howard W Sander; Arthur P Hays; Norman Latov
Journal:  Arch Neurol       Date:  2003-01

Review 5.  Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathy.

Authors:  Kenneth C Gorson; Anthony A Amato; Allan H Ropper
Journal:  Neurology       Date:  2004-08-24       Impact factor: 9.910

6.  Epidemiologic investigation of immune-mediated polyradiculoneuropathy among abattoir workers exposed to porcine brain.

Authors:  Stacy M Holzbauer; Aaron S DeVries; James J Sejvar; Christine H Lees; Jennifer Adjemian; Jennifer H McQuiston; Carlota Medus; Catherine A Lexau; Julie R Harris; Sergio E Recuenco; Ermias D Belay; James F Howell; Bryan F Buss; Mady Hornig; John D Gibbins; Scott E Brueck; Kirk E Smith; Richard N Danila; W Ian Lipkin; Daniel H Lachance; P James B Dyck; Ruth Lynfield
Journal:  PLoS One       Date:  2010-03-19       Impact factor: 3.240

7.  Derivation and validation of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy.

Authors:  C L Koski; M Baumgarten; L S Magder; R J Barohn; J Goldstein; M Graves; K Gorson; A F Hahn; R A C Hughes; J Katz; R A Lewis; G J Parry; P van Doorn; D R Cornblath
Journal:  J Neurol Sci       Date:  2008-12-16       Impact factor: 3.181

Review 8.  Polyneuropathy complicating bone marrow and solid organ transplantation.

Authors:  A A Amato; R J Barohn; Z Sahenk; P J Tutschka; J R Mendell
Journal:  Neurology       Date:  1993-08       Impact factor: 9.910

9.  Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome.

Authors:  O Watanabe; I Maruyama; K Arimura; I Kitajima; H Arimura; M Hanatani; K Matsuo; T Arisato; M Osame
Journal:  Muscle Nerve       Date:  1998-11       Impact factor: 3.217

10.  Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study.

Authors: 
Journal:  Lancet Neurol       Date:  2009-01-10       Impact factor: 44.182

View more
  11 in total

1.  Classical Complement Pathway Inhibition in a "Human-On-A-Chip" Model of Autoimmune Demyelinating Neuropathies.

Authors:  John W Rumsey; Case Lorance; Max Jackson; Trevor Sasserath; Christopher W McAleer; Christopher J Long; Arindom Goswami; Melissa A Russo; Shruti M Raja; Karissa L Gable; Doug Emmett; Lisa D Hobson-Webb; Manisha Chopra; James F Howard; Jeffrey T Guptill; Michael J Storek; Miguel Alonso-Alonso; Nazem Atassi; Sandip Panicker; Graham Parry; Timothy Hammond; James J Hickman
Journal:  Adv Ther (Weinh)       Date:  2022-04-05

2.  Feasibility of 7T MRI for imaging fascicular structures of peripheral nerves.

Authors:  Daehyun Yoon; Sandip Biswal; Brian Rutt; Amelie Lutz; Brian Hargreaves
Journal:  Muscle Nerve       Date:  2017-12-22       Impact factor: 3.217

3.  Lightning can strike twice: an unlucky patient of neurological interest.

Authors:  Ebony S Gilbee
Journal:  BMJ Case Rep       Date:  2013-06-24

4.  Predominant Upper Limb Chronic Demyelinating Polyneuropathy Associated with HBV Infection.

Authors:  Ioan-Cristian Lupescu; Adriana Octaviana Dulamea
Journal:  Maedica (Bucur)       Date:  2017-12

Review 5.  Association between chronic inflammatory demyelinating polyneuropathy and gastrointestinal malignancies.

Authors:  Adnan Malik; Rani Berry; Brian M Fung; James H Tabibian
Journal:  Clin J Gastroenterol       Date:  2020-11-04

6.  A comparative study of CIDP in a cohort of HIV-infected and HIV-uninfected patients.

Authors:  Kaminie Moodley; Pierre L A Bill; Vinod Bhagu Patel
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-12-15

7.  Demyelinating polyneuropathy and lymphoplasmacytic lymphoma coexisting in 36-year-old man: A case report.

Authors:  Lesia Rozłucka; Elżbieta Semik-Grabarczyk; Marta Pietrukaniec; Agnieszka Żak-Gołąb; Małgorzata Grabarczyk; Sebastian Grosicki; Michał Holecki
Journal:  World J Clin Cases       Date:  2020-06-26       Impact factor: 1.337

8.  Risk of osteoporosis in patients with chronic inflammatory neuropathy- a population-based cohort study.

Authors:  Seung Woo Kim; Eun Hwa Kim; Jinae Lee; Young-Chul Choi; Seung Min Kim; Ha Young Shin
Journal:  Sci Rep       Date:  2019-06-24       Impact factor: 4.379

9.  Acute-onset chronic inflammatory demyelinating polyneuropathy in hantavirus and hepatitis B virus coinfection: A case report.

Authors:  Jong Youb Lim; Young-Ho Lim; Eun-Hi Choi
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.817

10.  MRI biomarkers of proximal nerve injury in CIDP.

Authors:  Thorsten Lichtenstein; Alina Sprenger; Kilian Weiss; Karin Slebocki; Barbara Cervantes; Dimitrios Karampinos; David Maintz; Gereon R Fink; Tobias D Henning; Helmar C Lehmann
Journal:  Ann Clin Transl Neurol       Date:  2017-12-04       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.